Ratan Tata Invests In Invictus, A Startup Developing Anti-Cancer Drugs Which …

Ratan Tata Invests In Invictus, A Startup Developing Anti-Cancer Drugs Which …

Invictus Oncology utilises a supramolecular technology platform to design anti-cancer drugs that home into the tumour, and modulate the tumour immune response. The company claims that its lead molecule, IO 125, has already been validated in multiple …

(Visited 5 times, 1 visits today)
5
Like
Save

Comments

Comments are disabled for this post.